Plain language summary of zanubrutinib or ibrutinib in chronic lymphocytic leukemia that is resistant to treatment or has come back after treatment - Brown, Jennifer R; Eichhorst, Barbara; Hillmen, Peter; Jurczak, Wojciech; Kaźmierczak, Maciej; Lamanna, Nicole; O'Brien, Susan M; Tam, Constantine S; Qiu, Lugui; Zhou, Keshu; Simkovic, Martin; Mayer, Jiri; et al. (Future oncology (London, England), 2024)
Keywords: pyraziny; Humans; Antineoplastic Agents; Leukemia, Lymphocytic, Chronic, B-Cell; chemorezistence; Adenine; Pyrimidines; piperidiny; protinádorové látky; Protein Kinase Inhibitors; thiazoly; pyrimidiny; inhibitory proteinkinas; výsledek terapie; chronická lymfatická leukemie; Piperidines; Drug Resistance, Neoplasm; adenin; Treatment Outcome; lidé; Pyrazoles; Thiazoles; Pyrazines; pyrazoly